Skip to main content
Equibles

PYPD · PolyPid Ltd.

Track PYPD — free

Use PYPD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PYPD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.15 -0.01 (-0.19%) At close · Sep 11
Rebalance outlook locked
Market Cap
$104.61M
Shares
20.31M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.15 Open$5.20 Day$5.04–5.24 52W close$3.15–5.58 Avg vol 30d136K Short int195K · 1.0% float · 1.7d Short vol39% Last earningsAug 12, 2026 DataSep 2023–Sep 2026

Raw chart and full-history price indicators begin at the captured split on Sep 21, 2023; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 24, 2026 Est · unconfirmed · in 10 wks

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+155.6%
Year over year · more shares
Price change (1Y)
+49.3%
Trailing year
Short interest
1.0%
Latest settlement · 1.7 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Bullish Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +13%
above
Price vs 50-day avg +6%
above
RSI (14) 55
neutral
MACD trend Negative
52-week position 82%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +8%
trailing
6-month return +24%
trailing
YTD return +19%
this year
Relative strength +6%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow Accumulating
+65% holders QoQ · +13 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.96% of float · ▼ -15.7% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
33 holders — near 3-yr high, broad support
Squeeze score 49
elevated · 0–100
Fundamentals
Poor
EPS growth −57%
Y/Y
Free cash flow $-28.1M
Quant / Vol
risk profile
Very High
Volatility 56%
annualized · 1-yr
Max drawdown −33%
past year
ATR 5.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+13% Bullish
Price vs 50-day avg
+6% Bullish
RSI (14)
55 Neutral
MACD trend
Negative Bearish
52-week position
82% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow Accumulating
+65% holders QoQ · +13 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.96% of float · ▼ -15.7% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
33 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $5 · 82% Range high $6
vs 200-day avg +13% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PYPD
PolyPid Ltd.
this stock
$104.61M +18.7% — — 1.0%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.64B +13.7% +46.2% 30.0 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.46B +1.2% +20.8% 19.4 2.5%
ARGX
Argenx SE
 $61.22B +17.1% — — 2.0%
MRNA
Moderna, Inc.
 $57.48B +388.2% +4.3% — 9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
33
% held
16.2%
Net QoQ
+168.7K sh
Top holder
AIGH Capital Management L…
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
195.0K
Days to cover
1.7d
Change
-36.4K sh
View
Short Volume
Short vol %
39%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
617
Value
$2.9K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
54.9%
Week of
Aug 3, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-34.2M
EPS diluted
$2.09
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 12, 2026
This year
12
View
Exempt Offerings
Offering
$26.7M
Filed
Jun 23, 2025
View
Earnings & Events
Earnings Calls
Last call
Aug 12, 2026
View
Investor Relations
Latest news
PolyPid Provides Corporate Update…
Published
Aug 12, 2026
View

Performance

Raw-price comparisons begin at the captured split on Sep 21, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
PYPD -2.3% +7.7% +23.8% +0.2% +18.7%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -1.1% +9.5% +6.0% +0.6% +6.6%
Key facts CIK 1611842 CUSIP M8001Q126 13F (30d) 12 filings 12 filers Visit website Investor relations